MARISSA DAVIGNON: Open Payments
NPI 1962160580 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 60 payments from 8 companies in 2025. Trend: 2023 $1,919 · 2024 $1,847 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $992 |
| ABBVIE INC. | 22 | $744 |
| Lilly USA, LLC | 5 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Sandoz Inc. | 2 | $50 |
| Aimmune Therapeutics, Inc. | 1 | $31 |
| PFIZER INC. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: TREMFYA, SKYRIZI, RINVOQ, OMVOH, ENTYVIO, VOWST, XELJANZ, GATTEX.
Industry payments across NY — which companies pay providers there.
